Delek US Holdings, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report, dated May 2, 2024, details the results of Delek US Holdings, Inc.'s 2024 Annual Meeting of Stockholders held on the same date. The filing reports on the election of directors, executive compensation advisory votes, a charter amendment, and the ratification of auditors.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and voting outcomes.
Material Changes and Voting Results
- Election of Directors: All ten nominees were elected to the Board of Directors. While all were approved, Shlomo Zohar received the highest number of "Against" votes (5,664,431) compared to other nominees.
- Executive Compensation: The advisory resolution on executive compensation was approved with 48,688,926 votes "For" and 2,325,160 votes "Against."
- Charter Amendment: Stockholders approved an amendment to the Second Amended and Restated Certificate of Incorporation. This amendment expands officer exculpation provisions to align with new Delaware law, covering specific executive roles (e.g., CEO, CFO, President) and highly compensated officers for certain direct claims.
- Auditor Ratification: The appointment of Ernst & Young LLP as the independent registered public accounting firm for the 2024 fiscal year was ratified with 55,479,468 votes "For" and 1,857,944 votes "Against."
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, or specific business risks. The primary legal change noted is the expansion of exculpation protections for officers, which limits the scope of liability for certain direct claims against specified executives.
Key Facts for Investor Verification
- Verify the specific text of the Amendment to the Certificate of Incorporation (Exhibit 3.1) to understand the precise scope of the new officer exculpation provisions.
- Review the voting breakdown for Shlomo Zohar, who received significantly more "Against" votes than other director nominees.
- Confirm the effective date of the auditor ratification for the 2024 fiscal year.
- Note that this filing contains no financial performance data; refer to the most recent 10-Q or 10-K for financial metrics.